Polyneuropathy occurs when multiple peripheral nerves become damaged. Symptoms include problems with sensation, coordination, or other body functions. Polyneuropathy is also known as peripheral ...

Polyneuropathy occurs when multiple peripheral nerves malfunction throughout the body. Neuropathy is a common complication of type 2 diabetes mellitus (T2DM). Polyneuropathy occurs when there is ...

Peripheral neuropathy is a general term for nerve damage that causes weakness, numbness and pain, usually in your hands and feet. It can also affect other areas of your body and bodily functions ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated condition where inflammation damages the myelin sheath around peripheral nerves. Symptoms often develop slowly over at ...

Polyneuropathy, the condition that led to the death of Cincinnati Reds legend Joe Morgan, is a common form of a group of disorders known as peripheral neuropathy. The group of disorders causes damage ...

Emerging data suggest a possible genetic contributor to CIDP. In a recent study, patients with CIDP had a high frequency of perforin gene variations that impair the function of cytotoxic T and natural ...

CIDP treatment focuses on reducing and slowing the immune processes damaging your peripheral nervous system. It includes corticosteroids, intravenous immunoglobulin, and plasma exchange, but new ...

Please provide your email address to receive an email when new articles are posted on . Wainua has received regulatory approval for polyneuropathy of hereditary transthyretin-mediated amyloidosis.

What Is Hereditary Transthyretin Amyloidosis With Polyneuropathy? Hereditary transthyretin amyloidosis (hATTR) with polyneuropathy is a rare disorder passed down in families that gets worse over time.

Chronic inflammatory demyelinating polyneuropathy (CIDP) diagnoses are frequently missed or delayed and standard treatments -- intravenous immunoglobulin (IVIG), steroids, and plasma exchange -- are ...

– EU approval based on NEURO-TTRansform Phase 3 results showing WAINZUA demonstrated consistent and sustained benefit improving neuropathy impairment and quality of life versus placebo – CARLSBAD, ...